(Q55055726)

English

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

editorial

0 references

title

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms. (English)

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

1

Ayalew Tefferi

1 reference

stated in

Europe PubMed Central

PubMed ID

22375977

retrieved

16 June 2018

language of work or name

English

0 references

publication date

1 March 2012

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

volume

366

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

issue

9

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

page(s)

844-846

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

Identifiers

DOI

10.1056/NEJME1115119

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

PubMed ID

22375977

1 reference

stated in

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/22375977

(Q55055726)

Challenges facing JAK inhibitor therapy for myeloproliferative neoplasms.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)